The Valley Desk

NCT02164838 · Interventional trial

VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors

Overall registry status Completed

Phase 1

Conditions Refractory or Recurrent Solid Tumors, Excluding CNS Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov